Pathology of Tumors Associated With Pathogenic Germline Variants in 9 Breast Cancer Susceptibility Genes

Breast Canc Assoc Consortium, Mavaddat, N., Dorling, L., Carvalho, S., Blomqvist, C., Muranen, T. A. & Nevanlinna, H., mars 2022, I: JAMA Oncology. 8, 3, 11 s., 216744.

Forskningsoutput: Tidskriftsbidrag › Artikel › Vetenskaplig › Peer review

Rare germline copy number variants (CNVs) and breast cancer risk

NBCS Collaborators, CTS Consortium, ABCTB Investigators , kConFab-AOCS Investigators, Dennis, J., Tyrer, J. P., Walker, L. C., Muranen, T. A. & Nevanlinna, H., 18 jan. 2022, I: Communications Biology. 5, 1, 15 s., 65.

Forskningsoutput: Tidskriftsbidrag › Artikel › Vetenskaplig › Peer review

A search for modifying genetic factors in CHEK2: c.1100delC breast cancer patients

Wendt, C., Muranen, T. A., Mielikäinen, L., Thutkawkorapin, J., Blomqvist, C., Jiao, X., Ehrencrona, H., Tham, E., Arver, B., Melin, B., Kuchinskaya, E., Stenmark Askmalm, M., Paulsson-Karlsson, Y., Einbeigi, Z., Vappling, A. V. W., Kalso, E., Tasmuth, T., Kallioniemi, A., Aittomäki, K., Nevanlinna, H. & 2 andra, Borg, Å. & Lindblom, A., 20 juli 2021, I: Scientific Reports. 11, 1, 9 s., 14763.

Forskningsoutput: Tidskriftsbidrag › Artikel › Vetenskaplig › Peer review

Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment

NBCS Collaborators, ABCTB Investigators , kConFab Investigators, Morra, A., Escala-Garcia, M., Beesley, J., Muranen, T. A. & Nevanlinna, H., 18 aug. 2021, I: Breast Cancer Research. 23, 1, 18 s., 86.

Forskningsoutput: Tidskriftsbidrag › Artikel › Vetenskaplig › Peer review

Breast cancer risk factors and survival by tumor subtype: Pooled analyses from the breast cancer association consortium

Morra, A., Jung, A. Y., Behrens, S., Keeman, R., Ahearn, T. U., Anton-Culver, H., Arndt, V., Augustinsson, A., Auvinen, P. K., Beane Freeman, L. E., Becher, H., Beckmann, M. W., Blomqvist, C., Bojesen, S. E., Bolla, M. K., Brenner, H., Briceno, I., Brucker, S. Y., Camp, N. J., Campa, D. & 116 andra, Canzian, F., Castelao, J. E., Chanock, S. J., Choi, J-Y., Clarke, C. L., Couch, F. J., Cox, A., Cross, S. S., Czene, K., Dörk, T., Dunning, A. M., Dwek, M., Easton, D. F., Eccles, D. M., Egan, K. M., Evans, D. G., Fasching, P. A., Flyger, H., Gago-Dominguez, M., Gapstur, S. M., García-Sáenz, J. A., Gaudet, M. M., Giles, G. G., Grip, M., Guénel, P., Haiman, C. A., Håkansson, N., Hall, P., Hamann, U., Han, S. N., Hart, S. N., Hartman, M., Heyworth, J. S., Hoppe, R., Hopper, J. L., Hunter, D. J., Ito, H., Jager, A., Jakimovska, M., Jakubowska, A., Janni, W., Kaaks, R., Kang, D., Kapoor, P. M., Kitahara, C. M., Koutros, S., Kraft, P., Kristensen, V. N., Lacey, J. V., Lambrechts, D., Le Marchand, L., Li, J., Lindblom, A., Lubi-Nski, J., Lush, M., Mannermaa, A., Manoochehri, M., Margolin, S., Mariapun, S., Matsuo, K., Mavroudis, D., Milne, R. L., Muranen, T. A., Newman, W. G., Noh, D-Y., Nordestgaard, B. G., Obi, N., Olshan, A. F., Olsson, H., Park-Simon, T-W., Petridis, C., Pharoah, P. D. P., Plaseska-Karanfilska, D., Presneau, N., Rashid, M. U., Rennert, G., Rennert, H. S., Rhenius, V., Romero, A., Saloustros, E., Sawyer, E. J., Schneeweiss, A., Schwentner, L., Scott, C., Shah, M., Shen, C-Y., Shu, X-O., Southey, M. C., Stram, D. O., Tamimi, R. M., Tapper, W., Tollenaar, R. A. E. M., Tomlinson, I., Torres, D., Troester, M. A., Truong, T., Vachon, C. M., Wang, Q., Wang, S. S., Williams, J. A., Winqvist, R., Wolk, A., Wu, A. H., Yoo, K-Y., Yu, J-C., Zheng, W., Ziogas, A., Yang, X. R., Eliassen, A. H., Holmes, M. D., García-Closas, M., Teo, S. H., Schmidt, M. K., Chang-Claude, J., Investigators, T. ABCTB. & Collaborators, T. NBCS., apr. 2021, I: Cancer Epidemiology, Biomarkers & Prevention. 30, 4, s. 623-642 20 s.

Forskningsoutput: Tidskriftsbidrag › Artikel › Vetenskaplig › Peer review